trimer 4571

Vaccineexperimental

Clinical trial activity

5 trials · 9 clinical orgs · 0 marketing orgs

Phase 1
5
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Aug 17, 2021 (NCT04985760)

Timeline

2020s

  1. Jan 1, 2021

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06332339Phase 1Mar 15, 2024National Institute of Allergy and Infectious Diseases (NIAID)
NCT05781542Phase 1Apr 10, 2023Access to Advanced Health Institute (AAHI), Department of Health and Human Services, HIV Vaccine Trials Network, Inovio Pharmaceuticals, National Institute of Allergy and Infectious Diseases (NIAID), The Wistar Institute
NCT05828095Phase 1Apr 5, 2023National Institute of Allergy and Infectious Diseases (NIAID)
NCT05470400Phase 1Aug 15, 2022Department of Health and Human Services, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), University of Washington
NCT04985760Phase 1Aug 17, 2021National Institute of Allergy and Infectious Diseases (NIAID), University of Pittsburgh
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (9)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Institute of Allergy and Infectious Diseases (NIAID)Government5412021
Department of Health and Human ServicesGovernment2012022
Access to Advanced Health Institute (AAHI)Academic/Hospital1012023
HIV Vaccine Trials NetworkAcademic/Hospital1012023
Inovio PharmaceuticalsFor profit1012023
National Institutes of Health (NIH)Government1012022
The Wistar InstituteAcademic/Hospital1012023
University of PittsburghAcademic/Hospital1112021
University of WashingtonAcademic/Hospital1012022
9 organizations
Page 1 / 1